DDHD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.540400E-01
Normal-vs-Stage2
4.766800E-01
Normal-vs-Stage3
3.762200E-02
Normal-vs-Stage4
7.117200E-01
Stage1-vs-Stage2
9.584600E-01
Stage1-vs-Stage3
3.754400E-01
Stage1-vs-Stage4
6.259400E-01
Stage2-vs-Stage3
2.136000E-02
Stage2-vs-Stage4
6.452200E-01
Stage3-vs-Stage4
9.564100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.229600E-01
Normal-vs-AfricanAmerican
3.926800E-01
Normal-vs-Asian
6.402000E-02
Caucasian-vs-AfricanAmerican
9.477400E-01
Caucasian-vs-Asian
1.446410E-01
AfricanAmerican-vs-Asian
2.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.863800E-01
Normal-vs-Female
2.671000E-01
Male-vs-Female
8.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.405000E-01
Normal-vs-Age(41-60Yrs)
5.293400E-01
Normal-vs-Age(61-80Yrs)
5.168800E-01
Normal-vs-Age(81-100Yrs)
1.079420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.31550000001835E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.395100E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.532800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.946430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.360400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.168800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.051600E-02
Normal-vs-Daily Drinker
1.077830E-01
Normal-vs-Weekly Drinker
1.600580E-01
Normal-vs-Occasional Drinker
4.826000E-01
Normal-vs-Social Drinker
7.471200E-01
Non Drinker-vs-Daily Drinker
5.726000E-01
Non Drinker-vs-Weekly Drinker
5.302600E-01
Non Drinker-vs-Occasional Drinker
3.464200E-02
Non Drinker-vs-Social Drinker
8.636200E-02
Daily Drinker-vs-Weekly Drinker
8.987400E-01
Daily Drinker-vs-Occasional Drinker
1.452990E-01
Daily Drinker-vs-Social Drinker
1.679810E-01
Weekly Drinker-vs-Occasional Drinker
2.540400E-01
Weekly Drinker-vs-Social Drinker
2.294800E-01
Occasional Drinker-vs-Social Drinker
7.197200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.154180E-01
Normal-vs-Grade 2
1.353960E-01
Normal-vs-Grade 3
1.393670E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.294200E-01
Grade 1-vs-Grade 3
6.105600E-01
Grade 1-vs-Grade 4
1.154180E-01
Grade 2-vs-Grade 3
8.740000E-01
Grade 2-vs-Grade 4
1.353960E-01
Grade 3-vs-Grade 4
1.393670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.645780E-01
Normal-vs-NonDiabetic
5.471400E-01
Diabetic-vs-NonDiabetic
2.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.048430E-01
Normal-vs-NoPancreatitis
5.129400E-01
Pancreatitis-vs-NoPancreatitis
2.426600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.992200E-01
Normal-vs-N1
2.022200E-01
N0-vs-N1
3.346800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.869600E-01
Normal-vs-TP53-NonMutant
5.069800E-01
TP53-Mutant-vs-TP53-NonMutant
8.243400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
